An integrative literature review on the SARS-CoV-2 virus from 2015 to 2022
DOI:
https://doi.org/10.34119/bjhrv6n1-337Keywords:
Coronavirus, SARS-CoV-2, betacoronavirus, COVID-19Abstract
Coronaviruses of the order Nidovirales and families Coronaviridae, Arteriviridae, Mesoniviridae, Roniviridae were first isolated in 1937 and described in 1965. In 2019, the SARS-CoV-2 coronavirus was responsible for the coronavirus disease in 2019 (COVID-19) in Worldwide. Due to the great importance of SARS-CoV-2, this study integrated information about the virus, as a response: its origin, diagnosis and treatment, diagnosis and treatment. For this, a bibliographic survey was carried out in the Scielo, PubMed and Google Scholar databases regarding SARS-CoV-2, in order to describe its characteristics. SARS-CoV-2 does not yet have a well-clarified pathophysiology, it is known that it can cause an acute or chronic lung injury and that this condition resembles SARS-CoV, which results in aggressive inflammation initiated by viral replication. Both SARS-CoV and SARS-CoV-2 replicated similarly in alveolar epithelium, but SARS-CoV-2 replicates extensively in bronchial epithelium. Reverse transcription followed by polymerase chain reaction (RT-PCR) is widely used to identify viruses that cause respiratory secretions. Currently, with an ongoing viral pandemic, the importance of identifying the pathophysiological characteristics of SARS-CoV-2 and its serious impact on global public health becomes increasingly evident, especially with regard to the remarkable overload of health services, both private and public.
References
Abd El-Aziz, T. M., & Stockand, J. D. (2020). Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status. Infection, Genetics and Evolution, 83, 104327.
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature medicine, 26(4), 450-452.
Bolarin, J. A., Oluwatoyosi, M. A., Orege, J. I., Ayeni, E. A., Ibrahim, Y. A., Adeyemi, S. B., ... & Adeoye, A. B. E. (2021). Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective. International Immunopharmacology, 90, 107228.
Chang, Y. C., Tung, Y. A., Lee, K. H., Chen, T. F., Hsiao, Y. C., Chang, H. C., ... & Chen, C. Y. (2020). Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking.
Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology, 92(4), 418-423.
Cruz, M. P., Santos, E., Cervantes, M. V., & Juárez, M. L. (2021). COVID-19, una emergencia de salud pública mundial. Revista Clínica Española, 221(1), 55-61.
Cui, J., Li, F., & Shi, Z. L. (2019). Origin and evolution of pathogenic coronaviruses. Nature reviews microbiology, 17(3), 181-192.
de Lucena, T. M. C., da Silva Santos, A. F., de Lima, B. R., de Albuquerque Borborema, M. E., & de Azevêdo Silva, J. (2020). Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(4), 597-600.
De vacinação, P. M. COVID19. Direcao Geral de Saude.
Dias, V. M. C. H., Carneiro, M., & Lacerda Vidal, C. F. (2020). Orientações sobre diagnóstico, tratamento e isolamento de pacientes com COVID-19. J Infect Control, 9(2), 56-75.
dos Santos Pereira, C., Farias, J. R., Machado, P. R. P., Braga, G. L. C., Corôa, M. C. P., Ribeiro, R. M., ... & Varela, E. L. P. (2022). Amitriptyline: Useful for the prophylactic treatment of migraine?. Research, Society and Development, 11(10), e465111033013-e465111033013.
Emparan, J. P. O. D., Sardi-Correa, C., López-Ulloa, J. A., Viteri-Soria, J., Penniecook, J. A., Jimenez-Román, J., & Lansingh, V. C. (2020). COVID-19 and the eye: how much do we really know? A best evidence review. Arquivos brasileiros de oftalmologia, 83, 250-261.
Fani, M., Teimoori, A., & Ghafari, S. (2020). Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections. Future Virology, 15(5), 317-323.
Fehr, A. R., & Coronaviruses, P. S. An overview of their replication and pathogenesis. Maier H, Bickerton E, Britton P (eds) Coronaviruses Methods in Molecular Biology, 1282.
Forni, G., & Mantovani, A. (2021). COVID-19 vaccines: where we stand and challenges ahead. Cell Death & Differentiation, 28(2), 626-639.
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., ... & Qin, C. (2020). Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 369(6499), 77-81.
Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., ... & Ziebuhr, J. (2020). The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5(4), 536-544.
Guo, Y. R., Cao, Q. D., Hong, Z. S., Tan, Y. Y., Chen, S. D., Jin, H. J., ... & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military medical research, 7(1), 1-10.
Hashemian, S. M., Farhadi, T., & Velayati, A. A. (2020). A review on remdesivir: a possible promising agent for the treatment of COVID-19. Drug design, development and therapy, 14, 3215.
Hasöksüz, M., Kilic, S., & Saraç, F. (2020). Coronaviruses and sars-cov-2. Turkish journal of medical sciences, 50(9), 549-556.
Hui, K. P., Cheung, M. C., Perera, R. A., Ng, K. C., Bui, C. H., Ho, J. C., ... & Chan, M. C. (2020). Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. The Lancet Respiratory Medicine, 8(7), 687-695.
Jääskeläinen, A. J., Kekäläinen, E., Kallio-Kokko, H., Mannonen, L., Kortela, E., Vapalahti, O., ... & Lappalainen, M. (2020). Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Eurosurveillance, 25(18), 2000603.
Ji, W., Wang, W., Zhao, X., Zai, J., & Li, X. (2020). Homologous recombination within the spike glycoprotein of the newly identified coronavirus 2019-nCoV may boost cross-species transmission from snake to human. Journal of Medical Virology, doi, 10.
Kashte, S., Gulbake, A., El-Amin III, S. F., & Gupta, A. (2021). COVID-19 vaccines: rapid development, implications, challenges and future prospects. Human cell, 34(3), 711-733.
Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents, 55(3), 105924.
Li, D., Sempowski, G. D., Saunders, K. O., Acharya, P., & Haynes, B. F. (2022). SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment. Annual Review of Medicine, 73, 1-16.
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., ... & Feng, Z. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England journal of medicine.
Lima, E. J. D. F., Almeida, A. M., & Kfouri, R. D. Á. (2021). Vacinas para COVID-19-o estado da arte. Revista Brasileira de Saúde Materno Infantil, 21, 13-19.
Liu, P., Chen, W., & Chen, J. P. (2019). Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica). Viruses, 11(11), 979.
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., ... & Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet, 395(10224), 565-574.
Machado, P. R. P., dos Santos Pereira, C., da Silva, D. C. B., Varela, E. L. P., Corôa, M. C. P., Braga, G. L. C., ... & da Cruz, J. N. (2022). Atuação do farmacêutico no uso racional e manejo de antigripais: guia de prática clínica. Research, Society and Development, 11(8), e13711830526-e13711830526.
Melo, H. M., Paiva, M. J. M., & Carvalho, C. J. S. (2021). Pandemia do SARS-COV-2: uma revisão integrativa sobre os principais medicamentos, aprovados ou em fase de estudos, que podem ser utilizados no tratamento da COVID-19. Pubsaúde, 6, a151.
Memish, Z. A., Mishra, N., Olival, K. J., Fagbo, S. F., Kapoor, V., Epstein, J. H., ... & Lipkin, W. I. (2013). Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerging infectious diseases, 19(11), 1819.
Ndwandwe, D., & Wiysonge, C. S. (2021). COVID-19 vaccines. Current opinion in immunology, 71, 111-116.
Shoji, H., Fonseca, E. K. U. N., Teles, G. B. D. S., Passos, R. B. D., Yanata, E., Silva, M. M. A., ... & Szarf, G. (2020). Structured thoracic computed tomography report for COVID-19 pandemic. Einstein (São Paulo), 18.
Stasi, C., Fallani, S., Voller, F., & Silvestri, C. (2020). Treatment for COVID-19: An overview. European journal of pharmacology, 889, 173644.
Tang, A. N., Tong, Z. D., Wang, H. L., Dai, Y. X., Li, K. F., Liu, J. N., ... & Yan, J. B. (2020). Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerging infectious diseases, 26(6), 1337.
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 20(6), 363-374.
Teixeira, L. C. S. (2021). Comparação das vacinas Coronavac e Astrazeneca aprovadas para uso emergencial no Brasil.
Valencia, D. N. (2020). Brief review on COVID-19: the 2020 pandemic caused by SARS-CoV-2. Cureus, 12(3).
Wyllie, A. L., Fournier, J., Casanovas-Massana, A., Campbell, M., Tokuyama, M., Vijayakumar, P., ... & Ko, A. I. (2020). Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. New England Journal of Medicine, 383(13), 1283-1286.
Yan, Y., Pang, Y., Lyu, Z., Wang, R., Wu, X., You, C., ... & Pang, C. H. (2021). The COVID-19 vaccines: recent development, challenges and prospects. Vaccines, 9(4), 349.
Zhang, T., Wu, Q., & Zhang, Z. (2020). Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current biology, 30(7), 1346-1351.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., ... & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine.
